Drug or technology

Brivaracetam

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

JUL 13, 2026 · REGULATORY APPROVAL

FDA approval: Brivaracetam

U.S. Food and Drug Administration

FDA approval of an intravenous brivaracetam formulation; this is a regulatory action authorizing a new drug product, not a clinical trial outcome.

Regulatory UpdateShandong Brivaracetam

Reported

Approval date2026-07-13

Application typeANDA (Abbreviated New Drug Application)

Approved product strength and for…BRIVARACETAM 50MG/5ML (10MG/ML), SOLUTION,…

JUL 1, 2026 · REGULATORY APPROVAL

FDA approval: Brivaracetam

U.S. Food and Drug Administration

FDA approval of a generic brivaracetam formulation; establishes regulatory authorization but does not report clinical trial data or comparative efficacy evidence.

Regulatory UpdateSciegen Pharms Brivaracetam

Reported

Approval status date2026-07-01

Application typeANDA (abbreviated new drug application)